| Name | Title | Contact Details |
|---|---|---|
Mike Golebiowski |
SVP and Chief Marketing Officer | Profile |
Thomas Whalen |
VP, Corporate Financial Strategy | Profile |
Evan Bruck |
Director, Active Device Research and Development | Profile |
Brian Witkowski |
Director, Infusion Integration R&D | Profile |
Kyle Speck |
Director, Technical Accounting | Profile |
Motif Neurotech is a clinical-stage company leading the development of minimally invasive neuromodulation therapeutics for mental health. The company`s lead product, for treatment resistant depression (TRD), is a miniature implant that is designed to treat TRD by increasing activity in the prefrontal cortex. Studies over 20 years show stimulation of the pre-frontal cortex effectively treats treatment resistant depression without the side effects of anti-depressants. However, existing brain stimulation treatments like transcranial magnetic stimulation (TMS) can be expensive and challenging for patients to access, with daily treatments required for six weeks that may need to be repeated. Human and large animal studies show Motif`s prototype stimulates target brain areas like TMS, and the company is preparing to begin clinical trials of their first chronic implants in 2025. Motif`s implant is enabled by patent-pending wireless magnetoelectric power transfer developed at Rice University. Motif`s founders and key team members are clinical, medical device and academic experts with over 5,000 surgical procedures and decades of medical device experience.
Element Science is a San-Francisco based medical device and digital health start-up that develops lifesaving wearable solutions designed to deliver an outstanding experience.
NuGEN Technologies is a San Carlos, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Incisive Surgical is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Xenter, Inc. is a privately held company headquartered in Salt Lake City, Utah, that is focused on developing new wireless medical device technologies, innovative digital health tools that will enable individual patients to own and manage their health information, and novel therapeutic drugs utilizing Physical Intelligence™ and patient-supplied data. Xenter has assembled a team of medical scientists, chemical engineers, medical device engineers, researchers, data scientists, and some of the world`s most accomplished entrepreneurs and industry veterans to solve some of the largest challenges in healthcare, medicine and engineering.